## Abstract Impulsivity may be induced by therapeutic interventions (dopamine replacement therapies and subβthalamic nucleus (STN) stimulation) in patients with Parkinson's disease (PD). The present review has two goals. First, to describe the most frequently encountered facets of cognitive impulsi
Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease
β Scribed by Atbin Djamshidian; Ashwani Jha; Sean S. O'Sullivan; Laura Silveira-Moriyama; Clare Jacobson; Peter Brown; Andrew Lees; Bruno B. Averbeck
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 221 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Relatively little is known about the interaction between behavioral changes, medication, and cognitive function in Parkinson's disease (PD). We examined working memory, learning and risk aversion in PD patients with and without impulsive or compulsive behavior (ICB) and compared the results with those in a group of ageβmatched control subjects. Parkinson patients with PD+ICB had poorer working memory performance than either controls or PD patients without ICB. PD+ICB patients also showed decreased learning from negative feedback and increased learning from positive feedback in off compared with on dopaminergic medication. This interaction between medication status and learning was the opposite of that found in the PD patients without a diagnosis of ICB. Finally, the PD group showed increased risk preference on medication relative to controls, and the subgroup of PD+ICB patients with pathological gambling were overall more risk prone than the PD group. Thus, medication status and an impulsive behavioral diagnosis differentially affect several behaviors in PD. Β© 2010 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract Antiparkinson therapy can be the primary cause of a range of nonmotor symptoms that include a set of complex disinhibitory psychomotor pathologies and are linked by their repetitive, reward or incentiveβbased natures. These behaviors relate to aberrant or excessive dopamine receptor sti
## Abstract ## Background: Abnormal repetitive behaviors have been reported in Parkinson's disease (PD) during dopamine replacement therapy (DRT) and associated with individual predisposing features, including impulsivity. However, impulsivity and compulsive symptoms have never been explored in PD
## Abstract Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in firstβdegree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Id
## Abstract A range of behaviors presumed to be related to dopaminergic medications have been recently recognized in Parkinson's disease (PD). We evaluated 50 consecutive cognitively intact PD patients on stable dopamine agonist and levodopa therapy and 100 healthy controls for compulsive sexual be